Monogram provided an update regarding its 510(k) premarket filing submission to the FDA for the company’s mBos TKA System. The company has completed all supplemental testing and submitted its formal response to the FDA regarding the additional information request received on September 30, 2024. The company does not currently anticipate further requests for information from the agency.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRM: